Background: We examined the baseline characteristics and the rates of serious vascular events in randomized clinical trials after cerebral ischemia of presumed arterial origin to identify study features that predict vascular event incidence and to identify whether event rates have declined over time. Methods: We performed a systematic review to identify all published randomized controlled trials of patients with stroke or transient ischemic attack of presumed arterial origin that included an aspirin arm. We performed metaregression to analyze whether baseline features of included patients, design features and the year of study start and publication influenced vascular event rates under aspirin treatment. Results: Included studies comprised ...
Aims: Antiplatelet drugs are often discontinued early after ischaemic stroke, either because of poor...
Background and Purpose-Many randomized clinical trials have evaluated the benefit of long-term use o...
Objective: To study the early time course of major bleeding and its subtypes in patients with cerebr...
textabstractBackground and Purpose—Many randomized clinical trials have evaluated the benefit of lon...
BACKGROUND: The risk of recurrence following ischemic stroke or transient ischemic attack is highest...
Background: One quarter to one third of patients eligible for systemic thrombolysis are on antiplate...
Background: The prevalence of ex vivo ‘high on-treatment platelet reactivity (HTPR)’ and its relatio...
OBJECTIVE: To determine the effects of antiplatelet therapy among patients at high risk of occlusive...
Objective: To assess the the effect of antiplatelet therapy on the severity of subsequent stroke in ...
Background: Aspirin is recommended for secondary prevention after transient ischaemic attack (TIA) o...
Rationale: Antiplatelet agents such as aspirin, clopidogrel and dipyridamole are effective in reduci...
Background: The risk of recurrence following ischaemic stroke (IS) or transient ischaemic attack (TI...
International audienceBACKGROUND AND PURPOSE: The influence of prior antiplatelet therapy (APT) uses...
BACKGROUND: It is not always possible to verify whether a patient complaining of symptoms consistent...
Objective To determine the effects of antiplatelet therapy among patients at high risk of occlusive ...
Aims: Antiplatelet drugs are often discontinued early after ischaemic stroke, either because of poor...
Background and Purpose-Many randomized clinical trials have evaluated the benefit of long-term use o...
Objective: To study the early time course of major bleeding and its subtypes in patients with cerebr...
textabstractBackground and Purpose—Many randomized clinical trials have evaluated the benefit of lon...
BACKGROUND: The risk of recurrence following ischemic stroke or transient ischemic attack is highest...
Background: One quarter to one third of patients eligible for systemic thrombolysis are on antiplate...
Background: The prevalence of ex vivo ‘high on-treatment platelet reactivity (HTPR)’ and its relatio...
OBJECTIVE: To determine the effects of antiplatelet therapy among patients at high risk of occlusive...
Objective: To assess the the effect of antiplatelet therapy on the severity of subsequent stroke in ...
Background: Aspirin is recommended for secondary prevention after transient ischaemic attack (TIA) o...
Rationale: Antiplatelet agents such as aspirin, clopidogrel and dipyridamole are effective in reduci...
Background: The risk of recurrence following ischaemic stroke (IS) or transient ischaemic attack (TI...
International audienceBACKGROUND AND PURPOSE: The influence of prior antiplatelet therapy (APT) uses...
BACKGROUND: It is not always possible to verify whether a patient complaining of symptoms consistent...
Objective To determine the effects of antiplatelet therapy among patients at high risk of occlusive ...
Aims: Antiplatelet drugs are often discontinued early after ischaemic stroke, either because of poor...
Background and Purpose-Many randomized clinical trials have evaluated the benefit of long-term use o...
Objective: To study the early time course of major bleeding and its subtypes in patients with cerebr...